These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
769 related articles for article (PubMed ID: 25910483)
1. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Tsang CM; Tsao SW Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483 [TBL] [Abstract][Full Text] [Related]
2. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma. Zhang J; Jia L; Tsang CM; Tsao SW Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus infection and nasopharyngeal carcinoma. Tsao SW; Tsang CM; Lo KW Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937 [TBL] [Abstract][Full Text] [Related]
4. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748 [TBL] [Abstract][Full Text] [Related]
5. Etiological factors of nasopharyngeal carcinoma. Tsao SW; Yip YL; Tsang CM; Pang PS; Lau VM; Zhang G; Lo KW Oral Oncol; 2014 May; 50(5):330-8. PubMed ID: 24630258 [TBL] [Abstract][Full Text] [Related]
6. Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation. Yip YL; Lin W; Deng W; Jia L; Lo KW; Busson P; Vérillaud B; Liu X; Tsang CM; Lung ML; Tsao SW Lab Invest; 2018 Aug; 98(8):1093-1104. PubMed ID: 29769697 [TBL] [Abstract][Full Text] [Related]
7. Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus. Raab-Traub N Curr Top Microbiol Immunol; 2015; 390(Pt 1):339-63. PubMed ID: 26424653 [TBL] [Abstract][Full Text] [Related]
8. A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection. Ziegler P; Tian Y; Bai Y; Abrahamsson S; Bäckerholm A; Reznik AS; Green A; Moore JA; Lee SE; Myerburg MM; Park HJ; Tang KW; Shair KHY PLoS Pathog; 2021 Apr; 17(4):e1009041. PubMed ID: 33914843 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells. Tsang CM; Deng W; Yip YL; Zeng MS; Lo KW; Tsao SW Chin J Cancer; 2014 Nov; 33(11):549-55. PubMed ID: 25223910 [TBL] [Abstract][Full Text] [Related]
11. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514 [TBL] [Abstract][Full Text] [Related]
12. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027 [TBL] [Abstract][Full Text] [Related]
14. Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study. Yip YL; Pang PS; Deng W; Tsang CM; Zeng M; Hau PM; Man C; Jin Y; Yuen AP; Tsao SW PLoS One; 2013; 8(10):e78395. PubMed ID: 24167620 [TBL] [Abstract][Full Text] [Related]
15. EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis. Yang T; You C; Meng S; Lai Z; Ai W; Zhang J Front Cell Infect Microbiol; 2022; 12():935205. PubMed ID: 35846746 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345 [TBL] [Abstract][Full Text] [Related]
17. Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV. Ahmed N; Abusalah MAHA; Farzand A; Absar M; Yusof NY; Rabaan AA; AlSaihati H; Alshengeti A; Alwarthan S; Alsuwailem HS; Alrumaih ZA; Alsayyah A; Yean CY Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676626 [TBL] [Abstract][Full Text] [Related]
18. The role of Epstein-Barr virus in epithelial malignancies. Tsao SW; Tsang CM; To KF; Lo KW J Pathol; 2015 Jan; 235(2):323-33. PubMed ID: 25251730 [TBL] [Abstract][Full Text] [Related]
19. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers. Elgui de Oliveira D; Müller-Coan BG; Pagano JS Trends Microbiol; 2016 Aug; 24(8):649-664. PubMed ID: 27068530 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells. Lo AK; Lo KW; Ko CW; Young LS; Dawson CW J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]